Market Research Report
IVD Infectious Diseases Market Size, Share & Trends Analysis Report By Test Location, By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics), And Segment Forecast, 2019 - 2026
|Published by||Grand View Research, Inc.||Product code||818719|
|Published||Content info||78 Pages
Delivery time: 2-3 business days
|IVD Infectious Diseases Market Size, Share & Trends Analysis Report By Test Location, By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics), And Segment Forecast, 2019 - 2026|
|Published: March 1, 2019||Content info: 78 Pages||
The global in-vitro diagnostics infectious diseases market size is likely to reach USD 31.45 billion by 2026, according to a new report by Grand View Research, Inc., experiencing a CAGR of 6.7% during the forecast period. Increasing geriatric population and rising consumer awareness regarding the merits of IVD tests are expected to drive the IVD infectious diseases market.
Growing prevalence of target diseases, health awareness, and high demand for self-care medical devices are estimated to accentuate market growth over the forecast period. Moreover, introduction of technologically advanced products with improved sensitivity, speed, and user-friendliness are anticipated to increase the adoption of in-vitro diagnostics for infectious diseases in the next few years.
Key IVD techniques include immunochemistry assays, such as Enzyme-linked Immunosorbent Assay (ELISA) and Immuno-agglutination. These are widely used in clinical laboratories and diagnostic centers for detecting infectious microorganisms such as bacteria and virus in patient samples.
North America dominated the market, supported by presence of sophisticated healthcare infrastructure, government initiatives pertaining to research & development activities, and high awareness levels of patients and practitioners. The Asia Pacific IVD infectious diseases market is projected to witness the fastest growth over the forecast period.
Key players in the market include: Becton Dickinson; bioMerieux; Abbott Laboratories; Quidel Corporation; Alere Inc.; Orasure Technologies, Inc.; Hologic Inc.; Cepheid; Qiagen N.V.; Roche Diagnostics; Siemens Healthcare; and Bio-Rad Laboratories, Inc.